MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 185 filers reported holding MIRATI THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $10,803,000 | +5.7% | 61,065 | -3.5% | 1.12% | +9.4% |
Q2 2021 | $10,217,000 | +34.9% | 63,251 | +43.0% | 1.02% | +42.6% |
Q1 2021 | $7,575,000 | +27.3% | 44,218 | +63.2% | 0.72% | +14.0% |
Q4 2020 | $5,950,000 | +36.5% | 27,090 | +3.2% | 0.63% | -0.9% |
Q3 2020 | $4,358,000 | -45.3% | 26,245 | -62.4% | 0.64% | -50.1% |
Q2 2020 | $7,965,000 | +66.4% | 69,766 | +12.0% | 1.28% | +20.4% |
Q1 2020 | $4,787,000 | – | 62,272 | – | 1.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |